Table 2b.
HR | 95% CI | |||
---|---|---|---|---|
Diabetes (yes vs. no) | 3.11 | 2.51–3.86 | ||
BMI (Kg/m2) | ||||
< 23.15 | 1.00 | |||
23.16 - 25.38 | 1.50 | 1.14–1.96 | ||
25.39 - 28.06 | 1.86 | 1.43–2.42 | ||
> 28.07 | 2.24 | 1.74–2.89 | ||
Smoking habits | ||||
Never | 1.00 | |||
Past | 1.63 | 1.31–2.03 | ||
Intermittent | 1.86 | 1.25–2.76 | ||
Current | 2.09 | 1.66–2.62 | ||
CRP (mg/L) | ||||
< 0.70 | 1.00 | |||
0.71 - 1.40 | 1.25 | 0.92–1.71 | ||
1.41 - 2.80 | 1.82 | 1.38–2.39 | ||
> 2.81 | 2.54 | 1.96–3.31 | ||
Cystatin C (mg/L) | ||||
< 0.69 | 1.00 | |||
0.70 -0.76 | 1.51 | 1.11–2.05 | ||
0.77 -0.85 | 1.92 | 1.43–2.57 | ||
> 0.86 | 3.20 | 2.44–4.21 | ||
LpPLA2 activity (nmol/min/mL) | ||||
< 36.31 | 1.00 | |||
36.32 - 44.14 | 1.24 | 0.91–1.67 | ||
44.15 - 52.90 | 1.65 | 1.24–2.19 | ||
> 52.91 | 2.47 | 1.89–3.23 | ||
NTBNP (pg/mL) | ||||
< 34 | 1.00 | |||
35–61 | 0.81 | 0.61–1.06 | ||
62–112 | 0.87 | 0.67–1.14 | ||
> 113 | 1.41 | 1.10–1.80 | ||
NTBNP (309 pg/mL) | Yes vs. No | 2.43 | 1.70–3.49 |
CRP: C-Reactive Protein. LpPLA2: Lipoprotein-associated phospholipase A2. NTBNP: N-terminal B-type natriuretic peptide.